Literature DB >> 728339

Thiophene analogues of the carcinogens benzidine and 4-aminobiphenyl: evaluation in vitro.

J Ashby, J A Styles, D Anderson, D Paton.   

Abstract

A biologically active molecule with one or more aromatic rings often retains its activity when one of these rings is replaced by an isosteric and/or isoelectronic aromatic ring. Consideration has been given to whether this effect can be expected to apply to aromatic organic carcinogens. The literature relevant to this topic has been reviewed and the thiophene analogues of the carcinogens benzidine and 4-aminobiphenyl have been synthesized and evaluated for potential carcinogenicity. The compounds prepared were 5-p-acetamidophenyl-2-thiophenamine hydrochloride (XIII), 5-phenyl-2-thiophenamine hydrochloride (XIV), N-(5-p-acetamido-phenylthiophen-2-yl)acetamide (XV) and N-(5-phenylthiophen-2-yl)-acetamide (XVI) (see Chart for structures). Each compound was evaluated in the Salmonella reverse-mutation assay of Ames and the cell-transformation assay of Styles. The activity profiles observed for these compounds in vitro were consistent with their known chemistry, and indicate potential carcinogenicity. However, their overall chemical and biological behaviour casts doubt upon whether they would be capable of eliciting tumours in vivo. Because it is important to establish the degree of reliance which can be placed upon in vitro predictions of potential carcinogenicity generated for structurally new compounds, one of the thiophene derivatives, N-(5-phenylthiophen-2-yl)acetamide ((XVI), is currently being evaluated for carcinogenicity in mice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728339      PMCID: PMC2009770          DOI: 10.1038/bjc.1978.239

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

Review 1.  Biologically active benzo [b]thiophene derivatives. II.

Authors:  T R Bosin; E E Campaigne
Journal:  Adv Drug Res       Date:  1977

2.  Does carcinogenic potency correlate with mutagenic potency in the Ames assay?

Authors:  J Ashby; J A Styles
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

3.  Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system.

Authors:  C A Bigger; J E Tomaszewski; A Dipple
Journal:  Biochem Biophys Res Commun       Date:  1978-01-13       Impact factor: 3.575

Review 4.  Mutagenicity of polycyclic aromatic hydrocarbons.

Authors:  P Brookes
Journal:  Mutat Res       Date:  1977       Impact factor: 2.433

5.  Prevention of benzo(a)pyrene-induced mutagenicity by homogeneous epoxide hydratase.

Authors:  F Oesch; P Bentley; H R Glatt
Journal:  Int J Cancer       Date:  1976-10-15       Impact factor: 7.396

6.  In vitro evaluation of some derivatives of the carcinogen Butter Yellow: implications for environmental screening.

Authors:  J Ashby; J A Styles; D Paton
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

7.  A method for detecting carcinogenic organic chemicals using mammalian cells in culture.

Authors:  J A Styles
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

8.  An evaluation of 6 short-term tests for detecting organic chemical carcinogens.

Authors:  I F Purchase; E Longstaff; J Ashby; J A Styles; D Anderson; P A Lefevre; F R Westwood
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

9.  Selection of an in vitro carcinogenicity test for derivatives of the carcinogen hexamethylphosphoramide.

Authors:  J Ashby; J A Styles; D Anderson
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

10.  Potentially carcinogenic analogues of the carcinogen hexamethylphosphoramide: evaluation in vitro.

Authors:  J Ashby; J A Styles; D Paton
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

View more
  1 in total

1.  Potentially carcinogenic analogues of the carcinogen hexamethylphosphoramide: evaluation in vitro.

Authors:  J Ashby; J A Styles; D Paton
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.